Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
17 03 2020
Historique:
received: 03 10 2019
revised: 31 01 2020
accepted: 20 02 2020
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 24 3 2021
Statut: ppublish

Résumé

During metastasis, cancer cells are exposed to potentially destructive hemodynamic forces including fluid shear stress (FSS) while en route to distant sites. However, prior work indicates that cancer cells are more resistant to brief pulses of high-level FSS in vitro relative to non-transformed epithelial cells. Herein, we identify a mechano-adaptive mechanism of FSS resistance in cancer cells. Our findings demonstrate that cancer cells activate RhoA in response to FSS, which protects them from FSS-induced plasma membrane damage. We show that cancer cells freshly isolated from mouse and human tumors are resistant to FSS, that formin and myosin II activity protects circulating tumor cells (CTCs) from destruction, and that short-term inhibition of myosin II delays metastasis in mouse models. Collectively, our data indicate that viable CTCs actively resist destruction by hemodynamic forces and are likely to be more mechanically robust than is commonly thought.

Identifiants

pubmed: 32187555
pii: S2211-1247(20)30254-0
doi: 10.1016/j.celrep.2020.02.080
pmc: PMC7219793
mid: NIHMS1578463
pii:
doi:

Substances chimiques

RHOA protein, human 124671-05-2
Actomyosin 9013-26-7
Myosin Type II EC 3.6.1.-
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3864-3874.e6

Subventions

Organisme : NCI NIH HHS
ID : R21 CA179981
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM067795
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA196202
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA086862
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA174521
Pays : United States

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests M.D.H. is president, co-founder, and shareholder of SynderBio, Inc.

Références

J Biol Chem. 2003 Jan 31;278(5):2807-18
pubmed: 12429740
Biophys J. 2016 Jun 7;110(11):2528-2539
pubmed: 27276270
Am J Pathol. 2001 Jul;159(1):17-20
pubmed: 11438448
Microcirculation. 2006 Oct-Nov;13(7):597-610
pubmed: 16990218
Nat Cell Biol. 2015 Jul;17(7):943-52
pubmed: 26098574
Clin Exp Metastasis. 2005;22(8):674-84
pubmed: 16703413
Cancer Res. 2016 Nov 15;76(22):6577-6587
pubmed: 27680681
Cytometry A. 2004 Nov;62(1):46-53
pubmed: 15472900
Sci Adv. 2016 Apr 22;2(4):e1501337
pubmed: 27152338
Br J Cancer. 1999 Nov;81(5):756-9
pubmed: 10555742
Lab Chip. 2016 Aug 16;16(17):3330-9
pubmed: 27435631
Clin Exp Metastasis. 2014 Aug;31(6):697-704
pubmed: 24942131
Biorheology. 2009;46(2):77-81
pubmed: 19458411
Biophys J. 2019 Nov 5;117(9):1692-1701
pubmed: 31623884
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
PLoS One. 2012;7(10):e46609
pubmed: 23056368
Annu Rev Fluid Mech. 2005 Jan 1;37:43-69
pubmed: 21151769
Nat Commun. 2017 Jan 18;8:14122
pubmed: 28098159
J Biol Chem. 1996 Aug 23;271(34):20246-9
pubmed: 8702756
J Natl Cancer Inst. 1970 Oct;45(4):773-82
pubmed: 5513503
Cancer Res. 2011 Aug 1;71(15):5075-80
pubmed: 21642375
Integr Biol (Camb). 2018 Apr 23;10(4):218-231
pubmed: 29589844
Science. 1996 Jul 12;273(5272):245-8
pubmed: 8662509
Biochemistry. 2012 Sep 25;51(38):7420-32
pubmed: 22931484
Cytoskeleton (Hoboken). 2017 Nov;74(11):405-419
pubmed: 28921928
Biotechnol Bioeng. 2010 Aug 15;106(6):963-9
pubmed: 20589673
Cancer Res. 2000 May 1;60(9):2541-6
pubmed: 10811137
Cell Tissue Res. 2014 Mar;355(3):727-37
pubmed: 24643677
Cell. 1992 Aug 7;70(3):389-99
pubmed: 1643657
Semin Cell Dev Biol. 2015 Sep;45:2-9
pubmed: 26493704
PLoS One. 2017 Aug 25;12(8):e0183469
pubmed: 28841687
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
PLoS One. 2009 Aug 10;4(8):e6562
pubmed: 19668347
Nature. 2005 Aug 4;436(7051):725-30
pubmed: 16079851
J Hepatol. 1998 May;28(5):878-85
pubmed: 9625324
Cancer. 2015 Sep 15;121(18):3240-51
pubmed: 25975562
PLoS One. 2012;7(12):e50973
pubmed: 23226552
Cancer Discov. 2012 Dec;2(12):1091-9
pubmed: 23166151
Adv Cancer Res. 1990;54:159-211
pubmed: 1688681
Physiol Bohemoslov. 1975 Sep;24(5):413-9
pubmed: 127187
Cell Health Cytoskelet. 2015 Jan 9;7:25-35
pubmed: 25908902
Mol Cancer Ther. 2013 Sep;12(9):1886-95
pubmed: 23778153
Small GTPases. 2016 Oct;7(4):207-221
pubmed: 27628050
Lab Chip. 2013 Dec 7;13(23):4599-607
pubmed: 24100608
Am J Pathol. 2011 Jul;179(1):502-12
pubmed: 21703427
Am J Pathol. 1998 Sep;153(3):865-73
pubmed: 9736035
Annu Rev Biophys Biomol Struct. 1994;23:787-818
pubmed: 7919799
Cancer Growth Metastasis. 2015 Nov 29;8:43-9
pubmed: 26640389
Cell Adh Migr. 2011 Mar-Apr;5(2):170-80
pubmed: 21178402
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381539
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2913-8
pubmed: 22308368
Nat Commun. 2013;4:1883
pubmed: 23695677
Nat Rev Clin Oncol. 2017 Jan;14(1):32-44
pubmed: 27550857
Nat Rev Cancer. 2011 Jun 24;11(7):512-22
pubmed: 21701513
Cancer Res. 1950 Jun;10(6):357-9
pubmed: 15420702
Am J Physiol Cell Physiol. 2015 Dec 1;309(11):C736-46
pubmed: 26447202
Biophys J. 2017 Jul 25;113(2):461-471
pubmed: 28746856
Cancer Cell. 2017 Sep 11;32(3):282-293
pubmed: 28898694
Mol Biol Cell. 2020 Jul 21;31(16):1726-1734
pubmed: 31995446
J Biol Methods. 2018 Sep 05;5(3):e97
pubmed: 31453247
Mol Biol Cell. 2009 Apr;20(8):2207-17
pubmed: 19225155
Am J Physiol. 1993 Nov;265(5 Pt 2):H1787-96
pubmed: 8238592
Int J Oncol. 2017 Mar;50(3):993-1001
pubmed: 28197635

Auteurs

Devon L Moose (DL)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Cancer Biology Program, Biomedical Sciences, University of Iowa, Iowa City, IA 52242, USA.

Benjamin L Krog (BL)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Department of Biomedical Engineering, College of Engineering, University of Iowa, Iowa City, IA 52242, USA.

Tae-Hyung Kim (TH)

Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Lei Zhao (L)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Sophia Williams-Perez (S)

Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Gretchen Burke (G)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Lillian Rhodes (L)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Marion Vanneste (M)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Patrick Breheny (P)

Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA 52242, USA.

Mohammed Milhem (M)

Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA; Division of Hematology and Oncology, Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.

Christopher S Stipp (CS)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA; Department of Biology, University of Iowa, Iowa City, IA 52242, USA.

Amy C Rowat (AC)

Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Michael D Henry (MD)

Department of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA; Cancer Biology Program, Biomedical Sciences, University of Iowa, Iowa City, IA 52242, USA; Holden Comprehensive Cancer Center, Iowa City, IA 52242, USA; Departments of Pathology, Urology and Radiation Oncology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Electronic address: michael-henry@uiowa.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH